Get the Stockscreener App
261.50
1.67%
-4.44
After Hours:
261.50
Penumbra Inc stock is traded at $261.50, with a volume of 333.61K.
It is down -1.67% in the last 24 hours and up +10.21% over the past month.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
See More
Previous Close:
$265.94
Open:
$265.56
24h Volume:
333.61K
Relative Volume:
0.88
Market Cap:
$10.04B
Revenue:
$1.16B
Net Income/Loss:
$34.55M
P/E Ratio:
304.07
EPS:
0.86
Net Cash Flow:
$134.18M
1W Performance:
-2.79%
1M Performance:
+10.21%
6M Performance:
+52.53%
1Y Performance:
+1.12%
1-Day Range:
$259.79
$265.56
1-Week Range:
$259.58
$271.53
52-Week Range:
$148.00
$277.89
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
261.50 | 10.04B | 1.16B | 34.55M | 134.18M | 0.86 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
China Universal Asset Management Co. Ltd. Takes Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
E. Ohman J or Asset Management AB Has $5.06 Million Stock Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Calamos Advisors LLC Purchases Shares of 14,415 Penumbra, Inc. (NYSE:PEN) - MarketBeat
Washington Capital Management Inc. Makes New Investment in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra, Inc. (NYSE:PEN) Stake Lessened by SG Americas Securities LLC - MarketBeat
Penumbra, Inc. (NYSE:PEN) Shares Sold by Hantz Financial Services Inc. - MarketBeat
When the Price of (PEN) Talks, People Listen - Stock Traders Daily
Penumbra Launches Laser-Cut Hypotube Sheath Designed for Venous Thromboembolism - Diagnostic and Interventional Cardiology
Penumbra, Inc. (NYSE:PEN) Shares Bought by UMB Bank n.a. - Defense World
Penumbra started at buy by UBS on growth potential - MSN
Park Avenue Securities LLC Purchases 261 Shares of Penumbra, Inc. (NYSE:PEN) - Defense World
Penumbra (NYSE:PEN) Sets New 52-Week HighTime to Buy? - MarketBeat
Penumbra Stock Hits 52-Week High at $277.89 Amid Growth Optimism - Investing.com Australia
Penumbra Stock Hits 52-Week High at $277.89 Amid Growth Optimism By Investing.com - Investing.com South Africa
Penumbra (NYSE:PEN) Now Covered by Analysts at UBS Group - Defense World
Penumbra, Inc. (NYSE:PEN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
UBS Initiates Coverage of Penumbra (PEN) with Buy Recommendation - MSN
Reasons to Add Penumbra Stock to Your Portfolio Now - MSN
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025 - Kilgore News Herald
10 Analysts Assess Penumbra: What You Need To Know - Benzinga
UBS initiates Penumbra shares with Buy rating, projects 14% revenue CAGR through 2029 - Investing.com Australia
Penumbra (NYSE:PEN) Coverage Initiated by Analysts at UBS Group - MarketBeat
Peering Into Penumbra's Recent Short Interest - Benzinga
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN) - MSN
Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains? - MSN
Zacks.com featured highlights YPF Sociedad, Telefonica, Penumbra, Deckers Outdoor and Abercrombie & Fitch - Yahoo Finance
Abstract 160: Utilization of Penumbra MIDWAY 43 Catheter in Complex Neurovascular Interventions: Case Study Analysis - AHA Journals
Aneurysm Coiling and Embolization Devices Market to Grow by USD 2.0 Billion from 2025-2029, Driven by Rising IAS Cases and AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Penumbra, Inc. (NYSE:PEN) Shares Purchased by GAMMA Investing LLC - Defense World
Everence Capital Management Inc. Invests $304,000 in Penumbra, Inc. (NYSE:PEN) - Defense World
Penumbra stock rises following Stryker's Inari Medical acquisition By Investing.com - Investing.com Australia
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Kilgore News Herald
Penumbra stock rises following Stryker's Inari Medical acquisition - Investing.com India
Penumbra stock rises following Stryker’s Inari Medical acquisition By Investing.com - Investing.com Nigeria
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):